Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0Medical Science Monitor: International Medical Journal of Experimental and Clinical Research

A Pilot Clinical and Experimental Study of Type I Collagen Matrix Implantation Versus Microfracture for Knee Cartilage Defects

4 affiliations
  1. 1The First Affiliated Hospital of Anhui University of Science and Technology (Huainan First People’s Hospital), Huainan, Anhui, PR China
  2. 2School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, PR China
  3. 3Department of Sports Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, PR China
  4. 4Zhujiang Hospital, Southern Medical University, Guangzhou, Guangzhou, PR China

Abstract

Background: Microfracture is used to treat cartilage defects but may compromise subchondral bone integrity. Type I collagen matrix implantation has emerged as a potential alternative for advanced (Outerbridge III-IV) lesions, although supporting evidence remains limited. This study combined clinical evaluation with an animal model to validate treatment outcomes. The aim was to compare short-term clinical efficacy and cartilage repair quality of Type I collagen matrix implantation versus microfracture and to validate clinical findings in an animal model.

Material/Methods: This prospective, randomized, exploratory pilot translational study included both animal and clinical experiments. Full-thickness cartilage defects were created in 18 rats and treated with a blank control, microfracture, or Type I collagen implantation. After 12 weeks, gross and histological evaluations (Safranin O/Fast Green staining) were performed. Concurrently, 36 patients with knee cartilage defects were enrolled in a randomized, single-blind trial (collagen group, n = 20; microfracture group, n = 16) and followed for 12 months. Lysholm, International Knee Documentation Committee (IKDC), and Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores were recorded preoperatively (Lysholm and IKDC only) and at 3, 6, and 12 months postoperatively.

Results: In the animal model, Type I collagen implantation produced superior cartilage and subchondral bone repair compared with the control and microfracture groups. Clinically, both groups showed significant improvement; the collagen group consistently achieved higher functional and MOCART scores (P < 0.05).

Conclusions: Type I collagen matrix implantation was associated with more favorable cartilage regeneration and better short-term clinical outcomes than microfracture, representing an effective biomaterial-assisted treatment strategy for knee cartilage defects.

Related

  1. Mid-term clinical and radiologic outcomes of augmented microfracture with decellularized particulated costal allocartilage for knee cartilage defects: four-year prospective case series
    Kwangho Chung, Min Jung, Ki-Mo Jang +2
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  2. Effects of intra-articular micro-fragmented adipose tissue alone or combined with hyaluronic acid or collagen on cartilage degeneration and oxidative stress in an experimental rabbit osteoarthritis model.
    Alina Otilia Adam, Horea Rares Ciprian Benea, Luciana-Mădălina Gherman +4
    Medicine and pharmacy reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  3. Review of Experimental and Clinical Studies of Bovine Foetal Collagen Application
    Jordan Johnson, Daniella King, Mehul Satish Prabha +6
    Wound Repair and RegenerationPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  4. Favorable Short‐Term Outcomes for Minced Cartilage Implantation in Cartilage Defects of the Knee: A Systematic Review
    Alexander Tham, Osama Alzobi, Jared Rubin +5
    Arthroscopy, Sports Medicine, and RehabilitationPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMC
  5. Tacrolimus attenuates BCL-2/BAX-mediated chondrocyte apoptosis and cartilage matrix degradation in experimental osteoarthritis
    Huaze Zhu, Yun Chen, Bing Ruan +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
BibTeX
@article{zhu2026pilot,
  title = {{A Pilot Clinical and Experimental Study of Type I Collagen Matrix Implantation Versus Microfracture for Knee Cartilage Defects}},
  author = {Wei Zhu and Rongzhen Lin and Jinxi An and Wei Liu and Min Zhu and Peng Wu and Wei Li},
  journal = {Medical Science Monitor: International Medical Journal of Experimental and Clinical Research},
  year = {2026},
  month = nov,
  doi = {10.12659/msm.952142},
  url = {https://doi.org/10.12659/msm.952142},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - A Pilot Clinical and Experimental Study of Type I Collagen Matrix Implantation Versus Microfracture for Knee Cartilage Defects
AU  - Wei Zhu
AU  - Rongzhen Lin
AU  - Jinxi An
AU  - Wei Liu
AU  - Min Zhu
AU  - Peng Wu
AU  - Wei Li
PY  - 2026
DA  - 2026/11/08
JO  - Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
DO  - 10.12659/msm.952142
UR  - https://doi.org/10.12659/msm.952142
AB  - Background: Microfracture is used to treat cartilage defects but may compromise subchondral bone integrity. Type I collagen matrix implantation has emerged as a potential alternative for advanced (Outerbridge III-IV) lesions, although supporting evidence remains limited. This study combined clinical evaluation with an animal model to validate treatment outcomes. The aim was to compare short-term clinical efficacy and cartilage repair quality of Type I collagen matrix implantation versus microfracture and to validate clinical findings in an animal model.  Material/Methods: This prospective, randomized, exploratory pilot translational study included both animal and clinical experiments. Full-thickness cartilage defects were created in 18 rats and treated with a blank control, microfracture, or Type I collagen implantation. After 12 weeks, gross and histological evaluations (Safranin O/Fast Green staining) were performed. Concurrently, 36 patients with knee cartilage defects were enrolled in a randomized, single-blind trial (collagen group, n = 20; microfracture group, n = 16) and followed for 12 months. Lysholm, International Knee Documentation Committee (IKDC), and Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores were recorded preoperatively (Lysholm and IKDC only) and at 3, 6, and 12 months postoperatively.  Results: In the animal model, Type I collagen implantation produced superior cartilage and subchondral bone repair compared with the control and microfracture groups. Clinically, both groups showed significant improvement; the collagen group consistently achieved higher functional and MOCART scores (P < 0.05).  Conclusions: Type I collagen matrix implantation was associated with more favorable cartilage regeneration and better short-term clinical outcomes than microfracture, representing an effective biomaterial-assisted treatment strategy for knee cartilage defects.
SN  - 1234-1010
SN  - 1643-3750
ER  -